揭示贝贝林在神经保护中的分子机制,防止神经退行
Md Zamshed Alam Begh1, Md Al Amin1, Mst Maharunnasa Shatu2
1Department of Pharmacy, Faculty of Health and Life Sciences, Daffodil International University, Dhaka, Bangladesh.
Chemistry & biodiversity
|March 24, 2025
概括
柏柏林 (BBR) 在保护大脑细胞和治疗诸如阿尔茨海默氏症和帕金森症等神经退行性疾病方面表现有前途. 它的抗炎和抗氧化作用提供潜在的治疗益处,需要进一步的临床研究.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
背景情况:
- 由于有效治疗方法有限,神经退行性疾病 (NDs) 给全球健康带来了重大挑战.
- 柏柏林 (BBR) 是一种植物性类化合物,具有潜在的神经保护性.
- 现有研究表明,BBR可能为各种NDs提供治疗益处.
研究的目的:
- 审查柏柏林 (BBR) 在神经保护中的作用机制.
- 探索BBR在预防和治疗神经退行性疾病 (NDs) 中的治疗潜力.
- 总结关于BBR在NDs中的疗效的临床前和临床研究结果.
主要方法:
- 临床前研究 (细胞和动物模型) 和临床试验的文献综述.
- 对BBR多方面的神经保护作用的分析:抗炎,抗氧化,抗瘤和神经营养.
- 研究BBR对神经退行相关的关键信号通路的影响 (例如AMPK,PI3K/Akt,MAPK).
主要成果:
- BBR通过抗氧化剂,抗炎症,抗瘤和神经变作用表现出神经保护作用.
- BBR调节关键信号通路,例如AMP激活蛋白激酶 (AMPK),PI3K/Akt和MAPK.
- 临床前研究表明,BBR可以减少神经退行性病理并改善认知功能;早期临床试验是有希望的.
结论:
- 柏柏林 (BBR) 通过多种生物机制具有显著的神经保护潜力.
- 在预防和治疗神经退行性疾病 (NDs) 方面,BBR显示出前景.
- 进一步的临床研究对于确定BBR在人类患者中的安全性和有效性至关重要.
更多相关视频
08:16Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
Published on: June 17, 2015
18.1K
08:23Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line
Published on: August 9, 2014
11.4K
相关概念视频
00:49The Blood-brain Barrier
46.4K
Overview
46.4K
01:46Electron Transport Chain: Complex I and II
9.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.8K
01:22Alzheimer's Disease: Treatment
137
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
137
01:29Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K